Drug Screening in Human PSC-Cardiac Organoids Identifies Pro-proliferative Compounds Acting via the Mevalonate Pathway
Richard J. Mills(Royal Children's Hospital), James E. Hudson(The University of Queensland), Elise J. Needham(The University of Sydney), Lauren Drowley(UCB Pharma (United States)), David E. James(The University of Sydney), Ian P. Barrett(AstraZeneca (Australia)), Benjamin L. Parker(The University of Melbourne), Aurélie Bornot(Inserm), Holly K. Voges(Royal Children's Hospital), Enzo R. Porrello(Royal Children's Hospital), Gregory A. Quaife-Ryan(QIMR Berghofer Medical Research Institute), Maryam Clausen(AstraZeneca (Sweden)), David A. Elliott(The University of Melbourne), Magnus Polla(AstraZeneca (Sweden)), Qing‐Dong Wang(China Animal Disease Control Center), Henrik Andersson(AstraZeneca (Sweden)), Mei Ding(Ontario Institute for Cancer Research), Alleyn T. Plowright(AstraZeneca (Sweden))
Cited by 312
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Regulated transport of the glucose transporter GLUT4
|Nature Reviews Molecular Cell Biology|2002|1.2k
Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States
|Diabetes|2006|1.1k